UiPath, Inc. (NYSE:PATH) saw its shares rise 2.4% to $10.78 on Monday, tracking closely with the Invesco QQQ Trust (NASDAQ:QQQ) and outperforming the broader market. However, beneath the surface, the stock remains 6.0% below the average price of $11.47 at which the company repurchased shares in the first quarter, highlighting a lingering buyback gap.
The company's buyback activity has been substantial. In Q1 fiscal 2027, UiPath bought back 20.4 million Class A shares at an average of $11.47, followed by an additional 2.4 million shares from May 1 to May 15 at $9.63. With the current price at $10.78, the earlier tranche remains underwater, while the May purchases are showing a gain of 11.9%. Overall, the buyback has reduced the total Class A and B share count by 3.5% since January 31, from 537 million to 518.1 million as of May 29.
The financial impact of these repurchases is notable. UiPath spent $243.8 million on stock buybacks during the quarter, more than four times the $53.3 million in stock-based compensation. This aggressive capital return strategy underscores management's confidence, but it also puts pressure on operational performance to justify the investment.
Looking ahead, the primary focus for investors is the company's annual recurring revenue (ARR) trajectory. UiPath closed Q1 with $1.901 billion in ARR and guided Q2 to a range of $1.929 billion to $1.934 billion. The full-year fiscal 2027 target of $2.058 billion to $2.063 billion implies that the second half of the year must deliver $124 million to $134 million in net new ARR, assuming Q2 hits the midpoint. This is a significant step-up from the $28 million to $33 million expected in Q2.
CEO Daniel Dines highlighted that Q1 ARR grew 12% year-over-year, driven by agentic products transitioning from pilot to production. CFO Ashim Gupta noted that UiPath achieved GAAP profitability for the first time in Q1. Customer metrics also improved, with the number of clients generating at least $100,000 in ARR rising to 2,624 from 2,365 a year ago, and those with $1 million or more in ARR increasing to 374 from 316.
Valuation provides additional context. At Monday's close, UiPath's market capitalization stood at approximately $5.59 billion. After subtracting $1.42 billion in cash and marketable securities, the enterprise value is roughly $4.17 billion, or about 2.2 times Q1 ARR. This relatively low multiple suggests the market is pricing in the execution risk associated with the second-half ARR ramp.
Peer performance was mixed on Monday. UiPath's 2.4% gain outpaced Appian (NASDAQ:APPN) and ServiceNow (NYSE:NOW), while C3.ai (NYSE:AI) and Microsoft (NASDAQ:MSFT) declined. The stock's move was largely in line with the Nasdaq, reinforcing that the real story lies in the ARR guidance and buyback dynamics rather than the day's price action.
